Arrowhead Pharmaceuticals, Inc.

PANAGORA ASSET MANAGEMENT INC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

35,955

Value ($000)

2,387

Weight

0.0%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,387	0.0%	35,955	12/31/2025
2024 Q1	5/7/2024	530	0.0%	18,542	3/31/2024
2023 Q4	2/8/2024	2,609	0.0%	85,262	12/31/2023
2023 Q3	10/31/2023	5,565	0.0%	207,093	9/30/2023
2023 Q2	8/11/2023	9,044	0.1%	253,622	6/30/2023
2023 Q1	5/12/2023	6,365	0.0%	250,581	3/31/2023
2022 Q4	2/13/2023	9,978	0.1%	246,001	12/31/2022
2022 Q3	11/14/2022	7,257	0.1%	219,588	9/30/2022
2022 Q2	8/15/2022	563	0.0%	15,995	6/30/2022
2022 Q1	5/12/2022	736	0.0%	15,995	3/31/2022
2021 Q4	2/10/2022	1,060	0.0%	15,995	12/31/2021
2021 Q3	11/10/2021	999	0.0%	15,995	9/30/2021
2021 Q2	8/11/2021	1,475	0.0%	17,807	6/30/2021
2021 Q1	5/12/2021	1,441	0.0%	21,737	3/31/2021
2020 Q4	2/10/2021	1,668	0.0%	21,737	12/31/2020
2020 Q3	11/13/2020	936	0.0%	21,737	9/30/2020
2020 Q2	8/12/2020	3,715	0.0%	86,017	6/30/2020
2020 Q1	5/14/2020	5,594	0.0%	194,450	3/31/2020
2019 Q4	2/12/2020	17,703	0.1%	279,090	12/31/2019